Table 2.
Saline n (%) | Tenoxicam, 10 mg n (%) | Tenoxicam, 20 mg n (%) | ||
---|---|---|---|---|
Verbal Pain Scale | Group 1 (n = 40) | Group 2 (n = 40) | Group 3 (n = 40) | P |
0 (no pain) | 6 (15%) | 10 (25) | 16 (40)a | .013* |
1 (mild) | 8 (20%) | 10 (25%) | 14 (35%) | |
2 (moderate) | 14 (35%) | 14 (35%) | 8 (20%) | |
3 (severe) | 12 (30%) | 6 (15%) | 2 (5%)b | |
Overall incidence | 34 (85%) | 30 (75%)# | 24 (60%)** | .039* |
Data are presented as number of patients (%), * P < .05 was considered significant, # P = .264 compared with group 1, ** P = .012 compared with group 1.
aAccording to group 1, P = .033.
bAccording to group 1, P = .008.